Indiana Trust & Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AIM
AAMU
ECSS
ADEF
Indiana Trust & Investment Management's BIIB Position: Q2 2026 in Review
Indiana Trust & Investment Management held its Biogen (BIIB) position steady in Q2 2026 at 10 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #453.
Indiana Trust & Investment Management first reported a position in BIIB in Q3 2013 and has held it in 28 quarters since. The position peaked at $2.02M in Q1 2015. 373 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Indiana Trust & Investment Management held 10 shares of Biogen worth $2.16K as of Q2 2026.
- Indiana Trust & Investment Management left its Biogen share count unchanged in Q2 2026.
- Biogen made up ﹤0.01% of Indiana Trust & Investment Management's portfolio in Q2 2026, its #453 holding.
- Indiana Trust & Investment Management first reported a position in Biogen in Q3 2013 and has held it in 28 quarters since.
- Indiana Trust & Investment Management's Biogen position peaked at $2.02M in Q1 2015.
- 373 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Indiana Trust & Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.